Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Bernstein

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
The American Journal of Gastroenterology|November 15, 2017
The Cochrane Review Conclusion for Hepatitis C DAA Therapies is WrongPaul Y Kwo, Mitchell L Shiffman, David E Bernstein
The American Journal of Gastroenterology|June 20, 2018
Response to Perrella et alPaul Y Kwo, Mitchell L Shiffman, David E Bernstein
Digestive Diseases and Sciences|April 23, 2005
Peginterferon alpha-2a combination therapies in chronic hepatitis C patients who relapsed after or had a viral breakthrough on therapy with standard interferon alpha-2b plus ribavirin: a pilot study of efficacy and safetySteven K Herrine, Robert S Brown, David E Bernstein, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 30, 2018
Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirinJordan J Feld, David E Bernstein, Ziad Younes, et al.
Hepatology Communications|October 20, 2021
Community Socioeconomic Deprivation Predicts Nonalcoholic SteatohepatitisAlexa M Giammarino, He Qiu, Kishen Bulsara, et al.
European Journal of Gastroenterology & Hepatology|February 4, 2020
Thromboelastography versus standard coagulation testing in the assessment and reversal of coagulopathy among cirrhotics: a systematic review and meta-analysisAlexander J Kovalic, Muhammad Ali Khan, Diego Malaver, et al.
Gastrointestinal Endoscopy|June 23, 2020
Elective endotracheal intubation for urgent gastrointestinal endoscopy among hospitalized patients with SARS-CoV-2Praneet Wander, Daniel E Hogan, Sumant Inamdar, et al.
Digestive Diseases and Sciences|June 1, 2021
Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBVDavid E Bernstein, Huy N Trinh, Eugene R Schiff, et al.
European Journal of Gastroenterology & Hepatology|February 9, 2021
Severity of liver test abnormalities in coronavirus disease 2019 depends on comorbidities and predicts early in-hospital mortalitySanjaya K Satapathy, Christian Kuntzen, He Qiu, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 10, 2018
Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic SteatohepatitisUchenna Agbim, Yu Jiang, Satish K Kedia, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
The American Journal of Gastroenterology|November 15, 2017
The Cochrane Review Conclusion for Hepatitis C DAA Therapies is WrongPaul Y Kwo, Mitchell L Shiffman, David E Bernstein
The American Journal of Gastroenterology|June 20, 2018
Response to Perrella et alPaul Y Kwo, Mitchell L Shiffman, David E Bernstein
Digestive Diseases and Sciences|April 23, 2005
Peginterferon alpha-2a combination therapies in chronic hepatitis C patients who relapsed after or had a viral breakthrough on therapy with standard interferon alpha-2b plus ribavirin: a pilot study of efficacy and safetySteven K Herrine, Robert S Brown, David E Bernstein, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 30, 2018
Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirinJordan J Feld, David E Bernstein, Ziad Younes, et al.
Hepatology Communications|October 20, 2021
Community Socioeconomic Deprivation Predicts Nonalcoholic SteatohepatitisAlexa M Giammarino, He Qiu, Kishen Bulsara, et al.
European Journal of Gastroenterology & Hepatology|February 4, 2020
Thromboelastography versus standard coagulation testing in the assessment and reversal of coagulopathy among cirrhotics: a systematic review and meta-analysisAlexander J Kovalic, Muhammad Ali Khan, Diego Malaver, et al.
Gastrointestinal Endoscopy|June 23, 2020
Elective endotracheal intubation for urgent gastrointestinal endoscopy among hospitalized patients with SARS-CoV-2Praneet Wander, Daniel E Hogan, Sumant Inamdar, et al.
Digestive Diseases and Sciences|June 1, 2021
Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBVDavid E Bernstein, Huy N Trinh, Eugene R Schiff, et al.
European Journal of Gastroenterology & Hepatology|February 9, 2021
Severity of liver test abnormalities in coronavirus disease 2019 depends on comorbidities and predicts early in-hospital mortalitySanjaya K Satapathy, Christian Kuntzen, He Qiu, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 10, 2018
Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic SteatohepatitisUchenna Agbim, Yu Jiang, Satish K Kedia, et al.
Pageof 3